Last10K.com

Bovie Medical Corp (BVX) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2012

Bovie Medical Corp

CIK: 719135 Ticker: BVX
Document and Entity Information (USD $)
12 Months Ended
Dec. 31, 2012
Mar. 04, 2013
Jun. 30, 2012
Document and Entity Information [Abstract]      
Entity Registrant Name BOVIE MEDICAL CORP    
Entity Central Index Key 0000719135    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 46,300,000
Entity Common Stock, Shares Outstanding   17,788,177  
Document Fiscal Year Focus 2012    
Document Fiscal Period Focus FY    
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2012    

View differences made from one year to another to evaluate Bovie Medical Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Bovie Medical Corp.

Continue

Assess how Bovie Medical Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Bovie Medical Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Cash Flows (parenthetical)
Consolidated Statements Of Operations
Consolidated Statements Of Stockholders' Equity And Comprehensive Income (loss)
Description Of Business
Fair Value Measurements
Fair Value Measurements (details)
Fair Value Measurements (tables)
Gain From Legal Settlement
Gain From Legal Settlement (details)
Geographic And Segment Information
Geographic And Segment Information (details)
Geographic And Segment Information (tables)
Intangible Assets
Intangible Assets (details)
Intangible Assets (tables)
Line Of Credit
Line Of Credit (details)
Line Of Credit (tables)
Other Commitments And Contingencies
Other Commitments And Contingencies (details)
Other Commitments And Contingencies (tables)
Other Related Party Transactions
Other Related Party Transactions (details)
Other Subsequent Event
Other Subsequent Event (details)
Property, Plant And Equipment
Property, Plant And Equipment (details)
Property, Plant And Equipment (tables)
Recent Accounting Pronouncements
Retirement Plan
Retirement Plan (details)
Selected Quarterly Information (unaudited)
Selected Quarterly Information (unaudited) (details)
Selected Quarterly Information (unaudited) (tables)
Significant Accounting Policies
Significant Accounting Policies (details)
Significant Accounting Policies (policies)
Significant Accounting Policies (tables)
Stock Options
Stock Options (details)
Stock Options (tables)
Taxes And Net Operating Loss Carryforwards
Taxes And Net Operating Loss Carryforwards (details)
Taxes And Net Operating Loss Carryforwards (tables)
Trade Accounts Receivable
Trade Accounts Receivable (details)
Trade Accounts Receivable (tables)
Ticker: BVX
CIK: 719135
Form Type: 10-K Annual Report
Accession Number: 0001140361-13-014654
Submitted to the SEC: Mon Apr 01 2013 7:10:22 AM EST
Accepted by the SEC: Mon Apr 01 2013
Period: Monday, December 31, 2012
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/bvx/0001140361-13-014654.htm